https://doi.org/10.1038/nature07484
X
Xiaoli Feng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
223
Papers
10.2K
Citations
41
h-index
121
i10-index
Xiaoli Feng is an academic researcher from Qingdao University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & SARS-CoV-2 and COVID-19 Research & RNA modifications and cancer. The author has an h-index of 41, co-authored 190 publications.
ORCID: 0000-0002-7188-884XPapers by this author
worksThe diploid genome sequence of an Asian individual
2008 · Nature · 917 citations
Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
2021 · EBioMedicine · 123 citations
https://doi.org/10.1016/j.ebiom.2021.103803
High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation
2017 · Journal of Experimental & Clinical Cancer Research · 93 citations
https://doi.org/10.1186/s13046-017-0555-8
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
2022 · Cell Research · 76 citations
https://doi.org/10.1038/s41422-022-00746-3
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
2021 · Cell Research · 75 citations
https://doi.org/10.1038/s41422-021-00531-8
Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis
2011 · Molecular & Cellular Proteomics · 63 citations
https://doi.org/10.1074/mcp.m111.008821
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat